Oaktree Acquisition Corp. III Life Sciences (OACC) Stock
Financial Services · Shell Companies · Member of Other US Stocks
Oaktree Acquisition Corp. III Life Sciences (OACC) closed at USD 10.93 on 2026-10-14, a change of +2.7 % over the past year, with a market capitalization of USD 261.81M.
Oaktree Acquisition Corp. III Life Sciences recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 10.93 |
| 2026-10-13 | 10.75 |
| 2026-10-12 | 10.75 |
| 2026-10-09 | 10.75 |
| 2026-10-08 | 10.76 |
| 2026-10-07 | 10.76 |
| 2026-10-06 | 10.76 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Oaktree Acquisition Corp. III Life Sciences key figures
- Previous close
- USD 10.93 (2026-10-14)
- 1-year change
- +2.7 %
- Market cap
- USD 261.81M
- Enterprise value
- USD 260.64M
- P/E ratio (trailing)
- 38.04
- P/E ratio (forward)
- n/a
- EPS (trailing)
- 0.28
- EPS (forward)
- n/a
- PEG ratio
- n/a
- Price to book
- -34.92
- Revenue growth
- n/a
- Earnings growth
- -14.4 %
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.01
- Employees
- n/a
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Oaktree Acquisition Corp. III Life Sciences and compare it with other stocks.
Analyze OACCAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Oaktree Acquisition Corp. III Life Sciences shares.